High rates of multidrug-resistant and rifampicin-resistant tuberculosis among re-treatment cases: where do they come from?
about
A user-friendly mathematical modelling web interface to assist local decision making in the fight against drug-resistant tuberculosisTreatment outcomes of patients with multidrug-resistant and extensively drug resistant tuberculosis in Hunan Province, China.Multi-clonal evolution of multi-drug-resistant/extensively drug-resistant Mycobacterium tuberculosis in a high-prevalence setting of Papua New Guinea for over three decades.
P2860
High rates of multidrug-resistant and rifampicin-resistant tuberculosis among re-treatment cases: where do they come from?
description
2017 nî lūn-bûn
@nan
2017 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
High rates of multidrug-resist ...... ases: where do they come from?
@ast
High rates of multidrug-resist ...... ases: where do they come from?
@en
High rates of multidrug-resist ...... ases: where do they come from?
@nl
type
label
High rates of multidrug-resist ...... ases: where do they come from?
@ast
High rates of multidrug-resist ...... ases: where do they come from?
@en
High rates of multidrug-resist ...... ases: where do they come from?
@nl
prefLabel
High rates of multidrug-resist ...... ases: where do they come from?
@ast
High rates of multidrug-resist ...... ases: where do they come from?
@en
High rates of multidrug-resist ...... ases: where do they come from?
@nl
P2860
P50
P921
P1476
High rates of multidrug-resist ...... ases: where do they come from?
@en
P2093
Ben J Marais
P2860
P2888
P356
10.1186/S12879-016-2171-1
P407
P577
2017-01-06T00:00:00Z
P6179
1036171882